What You Should Know:
- RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, and iCAD, Inc., a global leader in AI-powered breast health solutions, announced that they have entered into a definitive merger agreement.
- Under the agreement, RadNet will acquire iCAD for $103M in an all-stock transaction.
Financial Details
Based on RadNet’s closing price on Monday, April 14, 2025, the transaction
Read More
Breast Cancer
GE HealthCare Launches AI-Powered Ultrasound for Enhanced Breast Cancer Detection in Dense Breasts
What You Should Know:
- GE HealthCare has unveiled Invenia™ Automated Breast Ultrasound (ABUS) Premium, a cutting-edge 3D ultrasound system designed to revolutionize breast cancer screening for women with dense breast tissue.
- The technology integrates artificial intelligence (AI) and innovative features to expedite supplemental screening, streamline exam readings, and improve detection accuracy.
AI-Driven 3D Breast Ultrasound
Dense breast tissue, present in a
Read More
iCAD, RamSoft Integrate to Enhance AI Breast Cancer Detection
What You Should Know:
- iCAD, Inc., a global leader in AI-powered cancer detection solutions, and RamSoft®, a provider of cloud-based radiology solutions announced a strategic partnership to integrate iCAD's ProFound AI® Breast Health Suite into RamSoft's PowerServer platform.
- The collaboration will bring advanced AI capabilities to imaging centers and healthcare providers across the US and Canada, enhancing breast cancer detection and improving patient care.
Addressing
Read More
SimonMed Imaging Launches AI-Powered Personalized Breast Cancer Detection Program
What You Should Know:
- SimonMed Imaging, a provider of outpatient medical imaging services in the United States, today announced the nationwide launch of its AI-enabled Personalized Breast Cancer Detection (PBCD) program.
- The program offers women a more comprehensive and personalized approach to breast cancer screening, empowering them to make informed decisions about their health.
PBCD Program Costs
For a cost of $40, patients can add the PBCD program to their
Read More
ScreenPoint Medical Acquires Biomediq to Enhance Breast Cancer Risk Assessment with AI
What You Should Know:
- ScreenPoint Medical, a provider of AI-powered breast cancer screening solutions, acquires Biomediq A/S, a research-based company specializing in quantitative imaging biomarkers. Financial details of the acquisition were not disclosed.
- ScreenPoint's industry-leading Transpara AI platform will now incorporate Biomediq's advanced risk analysis technology, which enables automated analysis of 2D and 3D mammograms to assess future breast cancer risk. This
Read More
GE HealthCare Unveils Mammography System to Improve Patient-Centered Breast Care
What You Should Know:
- GE HealthCare has announced the launch of its new Pristina Via™ mammography system, designed to improve the screening experience for both technologists and patients. This innovative system, debuting at the Radiological Society of North America's 2024 Annual Meeting, addresses the growing need for efficient workflows and personalized care in breast imaging.
- GE HealthCare developed Pristina Via™ based on extensive feedback from mammography technologists. The company
Read More
Lunit Partners with VIDI Group to Deliver AI-Powered Mammography to France’s Largest Radiology Network
What You Should Know:
- Lunit, a leading provider of AI-powered cancer diagnostics solutions, has announced a strategic alliance with VIDI Group, the largest private radiology and radiotherapy network in France.
- The partnership will expand the deployment of Lunit INSIGHT MMG, an AI solution for breast cancer screening, across VIDI's extensive network of over 400 sites and 1,200 doctors.
Improving Breast Cancer Detection
Lunit INSIGHT MMG is designed to assist
Read More
Baptist Health South Florida to Deploy MICA AI’s AI-Powered Mammograms
What You Should Know:
- MICA Artificial Intelligence and Baptist Health South Florida have joined forces in a groundbreaking collaboration to transform breast cancer detection.
- By integrating MICA AI's innovative technology into mammography, the collaboration aims to improve the accuracy and efficiency of breast cancer screening, leading to earlier diagnosis and better patient outcomes.
AI-Powered Mammogram Insights for Earlier Breast Cancer Detection
MICA AI, developed
Read More
Volpara Health Secures $7.3M Contract to Modernize Breast Cancer Screening for U.S. Military
What You Should Know:
- Volpara Health, a global leader in cancer detection software, has been awarded a significant contract with the U.S. Defense Health Agency (DHA) valued at $7.3M over five years.
- The contract will deploy Volpara's Patient Hub™ across the DHA's military health system, modernizing breast cancer screening and patient management for active-duty military personnel, retirees, and their families.
Enhancing Breast Health Management for Military
Read More
Vara Raises $8.9M to Expand AI-Powered Breast Cancer Screening Globally
What You Should Know:
- Vara, a Berlin, Germany-based provider of AI-enabled breast cancer detection, has announced the successful closure of a $8.9M (€8M EUR) Series B funding round.
- This investment, co-led by Smart Family Office, FJH, and IBB Ventures, will fuel Vara's continued expansion and its mission to revolutionize breast cancer screening through artificial intelligence.
Transforming Breast Cancer Screening with AI
Vara's AI-powered software has been shown to
Read More
